Over recent decades, medical schools and teaching hospitals have become increasingly dependent on industry support of their core educational missions. This reliance raises concerns because such support, including gifts, can influence the objectivity and integrity of academic teaching, learning, and practice, thereby calling into question the commitment of academia and industry together to promote the public’s interest by fostering the most cost-effective, evidence-based medical care possible. (AAMC, 2008c. iii) “Overall, research suggests that drug company representatives may influence prescribing patterns and requests for additions to hospital formularies.” “One review concluded that the “pharmaceutical industry has a significant presence during residency training, has gained the overall acceptance of trainees, and appears to influence prescribing behavior” (Zipkin and Steinman, 2005, p. 777). Another review (which was not limited to educational settings) concluded that detailing “affects physician prescription behavior in a positive [i.e., the more detailing that there is, the more of an effect that it has] and significant manner” (Manchanda and Honka, 2005, p. 787).” “The summary of a 2008 consensus conference held at the Mayo Clinic describes a conclusion that continuing medical education requires a “strategic management process that focuses on the integrity of an enterprise” and that deals “in a convincing, transparent and accountable manner issues such as commercial interest influence, conflicts of interest, bias, sources of evidence and the quality of product, process and delivery” (Kane, 2008, p. 8). It also stressed the need for research (and funding for research) to guide reforms.” ncbi.nlm.nih.gov/books/NBK22945/
Posted on: Thu, 13 Jun 2013 13:47:56 +0000
Trending Topics
Recently Viewed Topics
© 2015